Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Cristina SchöpfBiocenter, Institute of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0009-0005-9504-3736
Magdalena KnappDepartment of Zoology, University of Innsbruck, Innsbruck, Austria.
Jakob SchelerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Débora C Coraça-HuberResearch Laboratory for Implant Associated Infections (BIOFILM LAB), Experimental Orthopaedics, University Hospital for Orthopaedics and Traumatology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7664-5989
Alessandra RomanelliDepartment of Pharmaceutical Sciences, University of Milan, Milan, Italy.
Peter LadurnerDepartment of Zoology, University of Innsbruck, Innsbruck, Austria.
Anna C SeyboldDepartment of Zoology, University of Innsbruck, Innsbruck, Austria.
Ulrike BinderInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Reinhard WürznerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Florentine MarxBiocenter, Institute of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-8408-1842
Funding
Austrian Science Fund DOI 105576/I3132Austrian Science Fund DOI 10.55776/W1253Tiroler Nachwuchsforscher*innenfoerderung
6 · The paper itself
Abstract
Antimicrobial peptides (AMPs) have great potential to be developed as topical treatments for microbial infections of the skin, including those caused by the gram-positive human pathogen
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K. · full record | OpenQuestion